Download full-text PDF

Source

Publication Analysis

Top Keywords

case transfusional
4
transfusional plasmodium
4
plasmodium falciparum
4
falciparum malaria]
4
case
1
plasmodium
1
falciparum
1
malaria]
1

Similar Publications

Article Synopsis
  • Autologous Stem-Cell Transplantation (ASTC) is effective for treating certain blood cancers but can cause severe side effects due to intense chemotherapy.
  • The study presents a protocol for performing ASTC without transfusions, catering to patients who decline blood products, such as Jehovah's Witnesses (JW).
  • In a small trial with four patients (two with multiple myeloma and two with lymphomas), no serious complications occurred, and all patients remained alive and well at the time of reporting, showcasing the viability of the transfusion-free approach.
View Article and Find Full Text PDF

Thalassemia and hemochromatosis are two distinct conditions that involve dysregulation of iron metabolism, though their origin, clinical presentations, and treatments differ. This case represents a patient with incidentally discovered microcytic anemia due to β-thalassemia trait and non- hemochromatosis. It discusses the potential synergistic effect of these two diseases on iron overload and highlights the need for further testing to determine hereditary versus secondary causes of hemochromatosis.

View Article and Find Full Text PDF
Article Synopsis
  • Mosaic variegated aneuploidy (MVA) is a rare genetic disorder characterized by aneuploidies, mainly involving multiple chromosomes, leading to a variety of health issues like growth delay and congenital abnormalities.
  • A case study of a patient revealed a unique form of MVA with specific trisomies (mainly involving chromosomes 18 and 19) that caused intermittent mild neutropenia without severe symptoms over more than 20 years.
  • Genetic testing for known mutations related to MVA, as well as whole exome analysis, failed to identify any causative mutations, highlighting the complexity and uniqueness of this patient's condition.
View Article and Find Full Text PDF

How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency.

Hematol Rep

August 2024

Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.

Article Synopsis
  • Pyruvate kinase (PK) deficiency is an inherited condition causing chronic hemolytic anemia, with symptoms like fatigue, jaundice, and gallstones, typically managed with transfusions and other supportive therapies.
  • Mitapivat is a newly approved oral medication that activates RBC PK enzymes and has shown positive results in some patients by improving hemoglobin levels and reducing transfusion needs, though not all respond to it.
  • The response to mitapivat varies based on individual genetic factors, suggesting that both clinical symptoms and genetic background should be considered before starting treatment.
View Article and Find Full Text PDF

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

Am J Hum Genet

July 2024

Division of Psychological Medicine and Clinical Neurosciences, UK Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK. Electronic address:

Article Synopsis
  • * A study analyzed 4,685 sporadic FTD cases and found significant genetic variants at the MAPT and APOE loci that increase the risk for the disease, indicating potential genetic overlap with other neurodegenerative diseases.
  • * The genetic risk factors appear to vary by population, with MAPT and APOE associations predominantly found in Central/Nordic and Mediterranean Europeans, suggesting a need for further research into these population-specific features for better understanding of sporadic FTD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!